A new and more effective herpes zoster (shingles) vaccine, Shingrix®, is now available in all Albertsons Companies pharmacies across the United States.
Shingrix® was recently approved by the FDA and released to the public as a more effective vaccine for shingles, which is a reactivation of the chicken pox that shows up as a painful skin rash. Shingrix® is over 93% effective, compared to its predecessor Zostavax®, which was considered only 65% effective. It is also recommended for a wider range of adults, beginning at age 50, rather than Zostavax®, which was only recommended for those 60 and older.
1 in 3 people will get shingles in their lifetime, so it is recommended that anyone who is 50 and older, regardless of prior Zostavax® vaccination, receive Shingrix® to prevent getting shingles. Some people may be advised to wait up to 5 years after getting Zostavax® to get Shingrix®. The vaccine is especially important because as people age, their immune system weakens, leaving them more susceptible to shingles. Even healthy, active people can get shingles.
Those ages 50 and up are asked to speak with their pharmacist or healthcare professional about this vaccine.
- Shingrix vaccine gets FDA nod for the prevention of shingles
- Shingles vaccine, Shingrix, receives approval in Canada
- Shingles 101: Signs, symptoms and pain management